The multivariate analyses identified PEG-INF-alfa-2a (adjusted OR, 2.24; 95% CI, 1.45–3.45), fatty liver (adjusted OR, 1.76; 95% CI, 1.16–2.67), and liver cirrhosis (adjusted OR, 2.35; 95% CI, 1.35–4.09) as factors that increased the risk for EOT-ALT elevation in subjects with SVR. Here, GPT is linked to cirrhosis of liver.